Back to User profile » Dr Zuowei Wang
Papers published by Dr Zuowei Wang:
Efficacy and Safety of Remote Ischemic Conditioning for Depression Insufficiently Responsive to Antidepressant: A Randomized Controlled Trial
Wang J, Shuai Y, Ren M, Li N, Li X, Li W, Jiang B, Wang L, Huang L, Ji X, Wang Z
Neuropsychiatric Disease and Treatment 2025, 21:2279-2291
Published Date: 8 October 2025
Comparison of the Efficacy Between Standard Measurement-Base Care (MBC) and Enhanced MBC for Major Depressive Disorder: A Pilot Study
He Y, Wang X, Wang Z, Zhang P, Huang X, Yu M, Murphy JK, Michalak EE, Liu J, Yang T, Yang X, Fang Y, Lam RW, Chen J
Neuropsychiatric Disease and Treatment 2024, 20:1465-1473
Published Date: 29 July 2024
Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China
Zhu Y, Wu Z, Zhao D, Wu X, He R, Wang Z, Peng D, Fang Y
Neuropsychiatric Disease and Treatment 2023, 19:829-839
Published Date: 12 April 2023
Exploring the Effects of Temperament on Gray Matter Volume of Frontal Cortex in Patients with Mood Disorders
Yang T, Lam RW, Huang J, Su Y, Liu J, Yang X, Yang L, Zhu N, Zhao G, Mao R, Zhou R, Xia W, Liu H, Wang Z, Chen J, Fang Y
Neuropsychiatric Disease and Treatment 2021, 17:183-193
Published Date: 22 January 2021
Implementing Measurement-Based Care for Depression: Practical Solutions for Psychiatrists and Primary Care Physicians
Hong RH, Murphy JK, Michalak EE, Chakrabarty T, Wang Z, Parikh SV, Culpepper L, Yatham LN, Lam RW, Chen J
Neuropsychiatric Disease and Treatment 2021, 17:79-90
Published Date: 14 January 2021
Abnormal white matter integrity in Chinese young adults with first-episode medication-free anxious depression: a possible neurological biomarker of subtype major depressive disorder
Xia W, Zhou R, Zhao G, Wang F, Mao R, Peng D, Yang T, Wang Z, Chen J, Fang Y
Neuropsychiatric Disease and Treatment 2018, 14:2017-2026
Published Date: 10 August 2018